Sonoma Pharmaceuticals's market cap is currently $3.91M. The company's EPS TTM is $-3.933; its P/E ratio is ―; Sonoma Pharmaceuticals is scheduled to report earnings on February 18, 2025, and the estimated EPS forecast is $-0.73. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	$ 12.73M	$ 13.27M	$ 12.63M	$ 18.63M	$ 18.94M
Gross Profit	$ 4.75M	$ 4.48M	$ 3.99M	$ 6.56M	$ 8.33M
Operating Income	$ -4.70M	$ -4.57M	$ -5.89M	$ -3.45M	$ -6.67M
EBITDA	$ -4.53M	$ -4.45M	$ -5.70M	$ -3.22M	$ -3.22M
Net Income	$ -4.83M	$ -5.15M	$ -5.09M	$ -4.62M	$ -2.95M
Balance Sheet
Cash & Short-Term Investments	$ 3.13M	$ 3.82M	$ 7.40M	$ 4.22M	$ 3.69M
Total Assets	$ 14.74M	$ 16.23M	$ 18.84M	$ 14.99M	$ 14.56M
Total Debt	$ 608.00K	$ 849.00K	$ 1.37M	$ 2.67M	$ 1.48M
Net Debt	$ -2.52M	$ -2.97M	$ -6.03M	$ -1.54M	$ -2.21M
Total Liabilities	$ 8.60M	$ 8.25M	$ 10.15M	$ 9.62M	$ 5.86M
Stockholders' Equity	$ 6.14M	$ 7.98M	$ 8.70M	$ 5.36M	$ 8.71M
Cash Flow
Free Cash Flow	$ -2.42M	$ -6.42M	$ -4.38M	$ -3.56M	$ -4.80M
Operating Cash Flow	$ -2.40M	$ -6.15M	$ -4.25M	$ -3.38M	$ -4.59M
Investing Cash Flow	$ -2.00K	$ -258.00K	$ -99.00K	$ 388.00K	$ 3.64M
Financing Cash Flow	$ 1.68M	$ 2.49M	$ 7.40M	$ 3.31M	$ 1.03M

Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

Income Statement >

Sonoma Pharmaceuticals Debt to Assets

Balance Sheet >

Sonoma Pharmaceuticals Cash Flow

Cash Flow >

Sonoma Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing